TY  - JOUR
AU  - Sánchez Ramón, Silvia María
AU  - Eguíluz-Gracia I,
AU  - Rodríguez-Mazariego ME
AU  - Paravisini A
AU  - Zubeldia Ortuño, José Manuel
AU  - Gil-Herrera J
AU  - Fernández-Cruz Pérez, Eduardo
AU  - Suárez-Fernández R
PY  - 2012
UR  - https://hdl.handle.net/20.500.14352/115714
T2  - Journal of Investigational Allergology and Clinical Immunology
AB  - Background: Atopic dermatitis (AD) is a common chronic skin disease, and a significant percentage of AD patients have severe forms. Inflammation based on type 2 helper T cells (T(H)2), autoantibodies, and CD8+ T cells could play a relevant role in...
LA  - eng
M2  - 190
PB  - ESMON
KW  - topic dermatitis
KW  - Omalizumab
KW  - Rituximab
KW  - Autoimmunity.
KW  - Allergy.
TI  - Sequential Combined Therapy With Omalizumab and Rituximab: A New Approach to Severe Atopic Dermatitis
TY  - journal article
VL  - 23
ER  -